Smith & Nephew Advanced Wound Management Appoints David Hoffman To Lead Business Development

19 April 2006


Smith & Nephew's (LSE: SN; NYSE:SNN) Advanced Wound Management division today announced the appointment of David Hoffman as Senior Vice President, Business Development & Strategic Planning.

Hoffman joins Smith & Nephew from Boston Scientific Corporation where he has worked for 10 years most recently in their Endosurgery Group where he has been leading their New Market Development and Strategic Planning activity. Prior to his time with BSC he worked for Baxter Healthcare primarily in sales and international marketing roles.

"David has worked in the medical device industry for over 20 years in areas such as endoscopy, vascular, surgery and hospital supply. In that time he has gained a broad range of experience in strategic planning, business development, global marketing, market development for emerging technologies and sales management. He will be a valuable asset to Smith & Nephew", commented Joe Woody, President, Advanced Wound Management.

Hoffman will be a member of the Advanced Wound management Global Executive team, reporting to Joe Woody, President.

Hoffman holds a B.S. in Economics from Northwestern University and an M.B.A. from Butler University. He resides in Concord, Mass., with his wife and children.


About Smith & Nephew

Smith & Nephew (NYSE: SNN, LSE: SN) is a global medical technology business, specialising in Endoscopy, Orthopaedic Reconstruction, Orthopaedic Trauma and Advanced Wound Management products. Smith & Nephew ranks as the global leader in arthroscopy and one of the world's leaders in advanced wound management and is one of the fastest growing orthopaedics companies in the world.

Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has more than 8,500 employees and operates in 33 countries around the world and generated sales of nearly $2.6 billion.


Forward Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.